NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. Although this was…
Compass One Healthcare has announced its signature Healthcare Technology Management (HTM) brand: Intelas. Healthcare is evolving rapidly, and the need for integration, standardization, and scale is growing with it. Intelas exemplifies that and represents the next evolution of HTM at Compass…
After successfully presenting Hepatoscope at the DDW conference in San Diego and EASL in Amsterdam, French medical ultrasound company E-Scopics is continuing to present its unique liver assessment software system at the June 2025 American Diabetes Association conference in Chicago.…
Simulmedia, a national leader in data-driven TV and streaming advertising, today announced a strategic partnership with OptimizeRx Corp. a leading provider of healthcare technology solutions, to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT) audiences across linear, digital, and connected TV (CTV)…
Alcon (SIX/NYSE: ALC), the global eye care leader dedicated to helping people see with clarity, today announced the approval of the Clareon MD PanOptix MD Pro intraocular lens (IOL) for cataract patients in Canada. The PanOptix Pro IOL features ENLIGHTEN MD NXT optics , a proprietary…
In response to Harbour BioMed’s recent press release regarding a decision in its pending lawsuit, Biocytogen is issuing the following statement: Biocytogen operates in accordance with its core values: independent innovation, respect for intellectual property, and commitment to fair competition . The…
CharmHealth, a leader in healthcare technology solutions for providers, today announced that its 2025 Innovation Challenge continues to accept proposals from innovators, entrepreneurs and developers. The annual competition seeks fresh ideas that drive impact across the healthcare ecosystem. “The Innovation Challenge is…
A digital health leader revolutionizing AI-driven cardiometabolic care, today announced its selection by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. This national award recognizes top employers in the healthcare industry. The highly competitive selection process,…
Invivoscribe is pleased to announce that the NPM1 MRD Assay developed by its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine ® (LabPMM), has been approved by the State of New York. This approval comes just two months after the FLT3 ITD MRD Assay was approved…
The HRT Club, a leading pioneer of direct-to-consumer hormone replacement therapies, today announced a strategic partnership with Posterity Health, the leader in expert-led, comprehensive men’s health. Together, the two companies are creating a more robust and inclusive approach to hormonal health,…